• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report
We reported a patient with COVID-19 (confirmed with Lung HRCT scan and positive SARS-CoV-2 PCR) who developed acute progressive flaccid tetraparesis and maculopapular pigmented plaques on the limbs, 2  weeks after respiratory symptoms.
Source: Journal of Neuroimmunology - November 6, 2020 Category: Allergy & Immunology Authors: Reza Boostani, Fariborz Reazai Talab, Naser Tayyebi Meibodi, Fariba Zemorshidi Source Type: research

Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study
This study is a systematic comparison of the principal features of the inflammatory-like changes in the WM in different pathological conditions characterized by axonal damage/degeneration, focusing in particular on Multiple Sclerosis (MS) normal-appearing white matter (NAWM) compared to non immune-mediated disorders. The study was performed on sections of NAWM from 15 MS cases, 11 cases of non immune-mediated disorders with wallerian axonal degeneration (stroke, trauma, amyotrophic lateral sclerosis), 3 cases of viral encephalitis, 6 control cases.
Source: Journal of Neuroimmunology - September 8, 2017 Category: Allergy & Immunology Authors: M. Vercellino, C. Trebini, E. Capello, G.L. Mancardi, M.T. Giordana, P. Cavalla Source Type: research

A role for the complement alternative pathway in the pathology of multiple sclerosis grey matter lesions
In multiple sclerosis (MS), pathology of cortical and deep grey matter structures is predictive of a more rapid transit to the progressive phase and a more disabling disease. As all aspects of the complement system are activated in white matter (WM) lesions of progressive MS, we aim to understand the role of complement in the pathogenesis of grey matter (GM) lesions. We analysed the expression of classical (C1q, C4d), alternative (C3b–iC3b, Bb) and terminal (TCC) pathways of complement activation in post-mortem tissue from 22 progressive (13 SPMS, 9 male, median age at death 50years (38–66)); 8 inflammatory controls (v...
Source: Journal of Neuroimmunology - October 15, 2014 Category: Allergy & Immunology Authors: Lewis M. Watkins, Samantha Loveless, James Neal, Mark I. Rees, Neil Robertson, Richard Reynolds, B. Paul Morgan, Owain W. Howell Tags: 324 Source Type: research